☰

Nicole K. Brogden, Ph.D. - Publications

Affiliations: 
2012 Pharmaceutical Sciences University of Kentucky, Lexington, KY 
Area:
Pharmacy
Tree Info Similar researchers PubMed Report error

33 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Patel KK, Brogden NK. Impact of Formulation and Microneedle Length on Transdermal Metronidazole Permeation through Microneedle-Treated Skin. Pharmaceutical Research. PMID 38133717 DOI: 10.1007/s11095-023-03640-8  0.433
2023 Smith R, Brogden N, Fiegel J. Sprayable ciprofloxacin-loaded poloxamer hydrogels for wound infection treatment. Journal of Drug Delivery Science and Technology. 89. PMID 37928051 DOI: 10.1016/j.jddst.2023.105000  0.441
2023 Cai Q, Azarpanah A, Bhatt JA, Wei H, Carr J, Morris KR, Strasinger C, Brogden NK. Examination of the Rate and Extent of Drug Released from Commercial Topical Delivery Systems During Wear: An Example with Lidocaine Topical Systems. Pharmaceutical Research. PMID 37848751 DOI: 10.1007/s11095-023-03617-7  0.781
2023 Tobin KV, Brogden NK. Thermosensitive biomaterial gels with chemical permeation enhancers for enhanced microneedle delivery of naltrexone for managing opioid and alcohol dependency. Biomaterials Science. 11: 5846-5858. PMID 37455601 DOI: 10.1039/d3bm00972f  0.413
2023 Smith R, Ruben C, Pradhan O, Brogden N, Fiegel J. Spray Coverage Analysis of Topical Sprays Formed by Cold Thermoreversible Hydrogels. Drug Development and Industrial Pharmacy. 1-41. PMID 37354008 DOI: 10.1080/03639045.2023.2229919  0.42
2022 Russo J, Fiegel J, Brogden NK. Effect of Salt Form on Gelation and Drug Delivery Properties of Diclofenac-Loaded Poloxamer Gels for Delivery to Impaired Skin. Pharmaceutical Research. PMID 36002613 DOI: 10.1007/s11095-022-03356-1  0.537
2021 Ogunjimi AT, Lawson C, Carr J, Patel KK, Ferguson N, Brogden NK. Micropore Closure Rates following Microneedle Application at Various Anatomical Sites in Healthy Human Subjects. Skin Pharmacology and Physiology. 1-15. PMID 33910205 DOI: 10.1159/000515454  0.458
2021 Tobin KV, Fiegel J, Brogden NK. Thermosensitive Gels Used to Improve Microneedle-Assisted Transdermal Delivery of Naltrexone. Polymers. 13. PMID 33803552 DOI: 10.3390/polym13060933  0.473
2020 Russo J, Fiegel J, Brogden NK. Rheological and Drug Delivery Characteristics of Poloxamer-Based Diclofenac Sodium Formulations for Chronic Wound Site Analgesia. Pharmaceutics. 12. PMID 33333773 DOI: 10.3390/pharmaceutics12121214  0.454
2020 Ogunjimi AT, Carr J, Lawson C, Ferguson N, Brogden NK. Micropore closure time is longer following microneedle application to skin of color. Scientific Reports. 10: 18963. PMID 33144596 DOI: 10.1038/s41598-020-75246-8  0.36
2020 Ogunjimi AT, Fiegel J, Brogden NK. Design and Characterization of Spray-Dried Chitosan-Naltrexone Microspheres for Microneedle-Assisted Transdermal Delivery. Pharmaceutics. 12. PMID 32485999 DOI: 10.3390/Pharmaceutics12060496  0.633
2020 Swaminathan SK, Strasinger C, Kelchen M, Carr J, Ye W, Wokovich A, Ghosh P, Rajagopal S, Ueda K, Fisher J, Kandimalla KK, Brogden NK. Determination of Rate and Extent of Scopolamine Release from Transderm Scōp® Transdermal Drug Delivery Systems in Healthy Human Adults. Aaps Pharmscitech. 21: 117. PMID 32300962 DOI: 10.1208/S12249-020-01658-4  0.755
2020 Smith R, Russo J, Fiegel J, Brogden N. Antibiotic Delivery Strategies to Treat Skin Infections When Innate Antimicrobial Defense Fails. Antibiotics (Basel, Switzerland). 9. PMID 32024064 DOI: 10.3390/Antibiotics9020056  0.487
2019 Gao X, Brogden NK. Development of hydrogels for microneedle-assisted transdermal delivery of naloxone for opioid induced pruritus. Journal of Pharmaceutical Sciences. PMID 31476312 DOI: 10.1016/J.Xphs.2019.08.025  0.524
2018 Kelchen MN, Brogden NK. Effect of dosing regimen and microneedle pretreatment on in vitro skin retention of topically applied beta-blockers. Biomedical Microdevices. 20: 100. PMID 30523423 DOI: 10.1007/S10544-018-0348-7  0.571
2018 Kelchen MN, Brogden NK. In Vitro Skin Retention and Drug Permeation through Intact and Microneedle Pretreated Skin after Application of Propranolol Loaded Microemulsions. Pharmaceutical Research. 35: 228. PMID 30302631 DOI: 10.1007/S11095-018-2495-1  0.593
2018 Kelchen MN, Menon G, Ten Eyck P, Prettypaul D, Brogden NK. A Pilot Study to Evaluate the Effects of Topically Applied Cosmetic Creams on Epidermal Responses. Skin Pharmacology and Physiology. 31: 269-282. PMID 30110695 DOI: 10.1159/000490531  0.356
2017 Santos PL, Brito RG, Quintans JS, Araújo AA, Menezes IR, Brogden NK, Quintans-Júnior LJ. Cyclodextrins as Encapsulation Agents to Improve the Anti-inflammatory Drugs Profile: a Systematic Review and Meta-Analysis. Current Pharmaceutical Design. PMID 28128055 DOI: 10.2174/1381612823666170126121926  0.452
2016 Kelchen MN, Siefers KJ, Converse CC, Farley MJ, Holdren GO, Brogden NK. Micropore closure kinetics are delayed following microneedle insertion in elderly subjects. Journal of Controlled Release : Official Journal of the Controlled Release Society. 225: 294-300. PMID 26829102 DOI: 10.1016/J.Jconrel.2016.01.051  0.589
2015 Kinn PM, Holdren GO, Westermeyer BA, Abuissa M, Fischer CL, Fairley JA, Brogden KA, Brogden NK. Age-dependent variation in cytokines, chemokines, and biologic analytes rinsed from the surface of healthy human skin. Scientific Reports. 5: 10472. PMID 26035055 DOI: 10.1038/Srep10472  0.429
2014 Holdren GO, Rosenthal DJ, Yang J, Bates AM, Fischer CL, Zhang Y, Brogden NK, Brogden KA. Antimicrobial Activity of Chemokine CXCL10 for Dermal and Oral Microorganisms. Antibiotics (Basel, Switzerland). 3: 527-539. PMID 25859394 DOI: 10.3390/Antibiotics3040527  0.322
2014 Kelchen MN, Holdren GO, Farley MJ, Zimmerman MB, Fairley JA, Brogden NK. Optimization of impedance spectroscopy techniques for measuring cutaneous micropore formation after microneedle treatment in an elderly population. Pharmaceutical Research. 31: 3478-86. PMID 24947437 DOI: 10.1007/S11095-014-1435-Y  0.369
2014 Ghosh P, Brogden NK, Stinchcomb AL. Fluvastatin as a micropore lifetime enhancer for sustained delivery across microneedle-treated skin. Journal of Pharmaceutical Sciences. 103: 652-60. PMID 24395718 DOI: 10.1002/Jps.23844  0.84
2013 Milewski M, Paudel KS, Brogden NK, Ghosh P, Banks SL, Hammell DC, Stinchcomb AL. Microneedle-assisted percutaneous delivery of naltrexone hydrochloride in yucatan minipig: in vitro-in vivo correlation. Molecular Pharmaceutics. 10: 3745-57. PMID 24053426 DOI: 10.1021/Mp400227E  0.736
2013 Brogden NK, Banks SL, Crofford LJ, Stinchcomb AL. Diclofenac enables unprecedented week-long microneedle-enhanced delivery of a skin impermeable medication in humans. Pharmaceutical Research. 30: 1947-55. PMID 23761054 DOI: 10.1007/S11095-013-1036-1  0.816
2013 Ghosh P, Brogden NK, Stinchcomb AL. Effect of formulation pH on transport of naltrexone species and pore closure in microneedle-enhanced transdermal drug delivery. Molecular Pharmaceutics. 10: 2331-9. PMID 23590208 DOI: 10.1021/Mp3007083  0.795
2013 Brogden NK, Ghosh P, Hardi L, Crofford LJ, Stinchcomb AL. Development of in vivo impedance spectroscopy techniques for measurement of micropore formation following microneedle insertion. Journal of Pharmaceutical Sciences. 102: 1948-56. PMID 23589356 DOI: 10.1002/Jps.23544  0.78
2012 Brogden NK, Milewski M, Ghosh P, Hardi L, Crofford LJ, Stinchcomb AL. Diclofenac delays micropore closure following microneedle treatment in human subjects. Journal of Controlled Release : Official Journal of the Controlled Release Society. 163: 220-9. PMID 22929967 DOI: 10.1016/J.Jconrel.2012.08.015  0.815
2012 Brogden NK, Mehalick L, Fischer CL, Wertz PW, Brogden KA. The emerging role of peptides and lipids as antimicrobial epidermal barriers and modulators of local inflammation. Skin Pharmacology and Physiology. 25: 167-81. PMID 22538862 DOI: 10.1159/000337927  0.305
2011 Banks SL, Paudel KS, Brogden NK, Loftin CD, Stinchcomb AL. Diclofenac enables prolonged delivery of naltrexone through microneedle-treated skin. Pharmaceutical Research. 28: 1211-9. PMID 21301935 DOI: 10.1007/S11095-011-0372-2  0.803
2010 Paudel KS, Milewski M, Swadley CL, Brogden NK, Ghosh P, Stinchcomb AL. Challenges and opportunities in dermal/transdermal delivery. Therapeutic Delivery. 1: 109-31. PMID 21132122 DOI: 10.4155/Tde.10.16  0.683
2010 Milewski M, Brogden NK, Stinchcomb AL. Current aspects of formulation efforts and pore lifetime related to microneedle treatment of skin. Expert Opinion On Drug Delivery. 7: 617-29. PMID 20205604 DOI: 10.1517/17425241003663228  0.837
2010 Banks SL, Pinninti RR, Gill HS, Paudel KS, Crooks PA, Brogden NK, Prausnitz MR, Stinchcomb AL. Transdermal delivery of naltrexol and skin permeability lifetime after microneedle treatment in hairless guinea pigs Journal of Pharmaceutical Sciences. 99: 3072-3080. PMID 20166200 DOI: 10.1002/Jps.22083  0.81
Show low-probability matches.